文献速递肿瘤 PET/CT

FDG PET/CT揭示母细胞性浆细胞样树突细胞肿瘤隐匿淋巴结病变

Revealing Hidden Nodal Disease: FDG PET/CT Driven Detection of Occult Lymph Node Involvement in Blastic Plasmacytoid Dendritic Cell Neoplasm.
PubMed 文献 · Clin Nucl Med · 2026-04-16

本文报告一例32岁男性母细胞性浆细胞样树突细胞肿瘤(BPDCN)患者,表现为多发紫罗兰色皮肤结节,行F-18 FDG PET/CT分期。PET/CT显示皮肤病灶广泛代谢活跃,并发现此前未疑及的腹股沟和颈部淋巴结受累,组织病理学确诊BPDCN。作者认为FDG PET/CT在检出亚临床淋巴结病变、描绘总体疾病负荷和提高分期准确性方面具有重要价值。

要点

  • BPDCN常伴皮肤受累并可全身播散,FDG PET/CT可显示皮肤病灶代谢活跃。
  • 本病例中PET/CT发现临床未疑及的腹股沟和颈部淋巴结受累。
  • FDG PET/CT有助于提高BPDCN分期准确性并指导后续管理。

核心结论

  • FDG PET/CT在BPDCN中可检出亚临床淋巴结病变、描绘总体疾病负荷并提高分期准确性,支持其用于指导管理和后续疗效评估。

研究设计与样本

  • 本文为个案报告,对象为一名32岁男性多发紫罗兰色皮肤结节患者,因分期接受F-18 FDG PET/CT检查,并经组织病理学确诊BPDCN。

主要发现

  • PET/CT显示皮肤部位广泛代谢活跃,并发现此前未疑及的腹股沟和颈部淋巴结受累。

临床怎么用

  • 对BPDCN患者分期时,可考虑FDG PET/CT以检出隐匿淋巴结病变并更完整评估疾病范围。

局限性

  • 本文为单例个案报告,未提供样本量、疗效或随访结局等系统性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive malignancy characterized by skin involvement and frequent systemic dissemination. We report a case of a 32-year-old man with multiple violaceous cutaneous nodules who underwent F-18 FDG PET/CT for staging. PET/CT demonstrated extensive metabolic activity in cutaneous sites and revealed previously unsuspected inguinal and cervical lymph-node involvement. Histopathology confirmed BPDCN. This case highlights the crucial role of FDG PET/CT in detecting subclinical nodal disease, delineating total disease burden, and improving staging accuracy in BPDCN, thereby supporting its value in guiding management and future response assessment.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kundu N, Krishna J, Kumar R, et al. Revealing Hidden Nodal Disease: FDG PET/CT Driven Detection of Occult Lymph Node Involvement in Blastic Plasmacytoid Dendritic Cell Neoplasm. Clin Nucl Med. 2026. PMID: 42029091. doi:10.1097/RLU.0000000000006474

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。